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a b Figure S1 . Characterization of active molecules in the culture supernatant of the prototrophic strain.
(a) Five hundred microliters of the supernatant of the prototrophic strain (SpHT219) cultured in EMM
[Glu]+ILV+AU was extracted, separately with hexane, EtOAc, or BuOH. The organic layers and aqueous layers (aqu) were dried and redissolved separately in 50% MeOH to examine their activities. eca39Δ cells Supernatant prepared as in (a) was adjusted to pH 3, 7, or 10, and then extracted with EtOAc. The organic layers and aqueous layers (aqu) were adjusted to a pH of 5.5. All of the layers were dried and redissolved separately in 50% MeOH to examine their activities. eca39Δ cells (SpHT257) suspended in water at OD 600 = 0.2 or 0.4 were spotted onto EMM (Glu)+ILV+AU. Fission yeast prototrophic cell supernatant (sup) and solvent (50% MeOH) were used as positive and negative controls (NC), respectively. The plates were incubated at 30°C for 10 days. A representative result is shown; the experiment was performed three times.
Based on the observation that the organic layers of supernatant adjusted to pH 3 had stronger activity, we concluded that the active molecules were acidic and lipid-soluble. Figure S2 . Adaptive growth-inducing activities of fractions 1 and 2.
Isolated fractions were dissolved in 50% MeOH, and a 2-fold dilution series of the compounds was prepared with a starting concentration of 2.5×10 4 ng/mL to examine the activities. Those dilutions were layered onto solid EMM [Glu] +ILV+AU. Supernatant of the prototrophic strain (SpHT219) (sup) and solvent (50% MeOH) were used as positive and negative controls (NC), respectively. eca39Δ cells (SpHT257) suspended in water at OD 600 = 0.4 were spotted onto the solid media, and the plates were incubated at 30°C for 6 days.
For fraction 1, the experiment was performed twice, and a representative result is shown. Due to the limited quantity of fraction 2, the experiment was performed only once. (a) ESI-MS/MS spectrum (negative) of fraction 2. A significant fragmentation ion peak was observed at m/z 155.1 (arrow), indicating the double bond positioned at C-8. (b) Activity of synthetic racemic 10-hydroxy-8(E)-octadecenoic acid (3). The compound was dissolved in 50% MeOH, and a 2-fold dilution series was prepared with a starting concentration of 5.0×10 4 ng/mL to examine the activity by spot assay.
The dilutions were layered onto solid EMM [Glu] +ILV+AU. The supernatant of the prototrophic strain (SpHT219) (sup) and solvent (50% MeOH) were used as positive control and negative controls (NC), respectively. Plates were incubated at 30°C for 12 days. The experiment was performed twice, and a representative result is shown. (c) GC-MS chromatogram of fraction 2 and mass spectra of the major peak and the minor peak. The fraction 2 sample was trimethylsilylated and subjected to GC-MS analysis. 
!"CB! HPLC chromatogram of co-injection of fraction 2 and (R)-2 was shown in the right panel. The peak of (R)-2 (purple arrowhead) corresponds to the peak at T R 14.5 of fraction 2 (red arrowhead). The peak indicated with a blue arrowhead (fraction 2) corresponds to 10-hydroxy-8(E)-octadecenoic acid (3). (c) MS spectra of the major peak of the isolated fraction 2, minor peak of the isolated fraction 2, peak at T R 11.19 of 3, and peak of T R 11.19 of (R)-2. See Figure 2c . 
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Figure S7. Examination of activities of structurally related compounds.
Six compounds (4-9) were dissolved in 50% MeOH. A 2-fold or 3-fold dilution series of each compound was prepared for examination of their activities by spot assay. eca39Δ cells (SpHT257) suspended in water at OD 600 = 0.4 were spotted onto EMM [Glu]+ILV+AU layered with each diluted compound. Prototrophic cell supernatant (sup) and solvent (50% MeOH) were used as the positive and negative control (NC), respectively. Plates were incubated for 8 days or 10 days. A representative result is shown; the experiment was performed twice. 4: 10-hydroxy-8-octadecynoic acid, 5: 10-hydroxy-octadecanoic acid, 6: oleic acid (9(Z)-octadecenoic acid), 7: ricinoleic acid (12-hydroxy-9(Z)-octadecenoic acid),
8:
7,10-dihydroxy-8(Z)octadecenoic acid, 9: 6-hydroxy-4(E)-octadecenoic acid. (a) Supernatant of prototrophic cell culture (SpHT219) was extracted with EtOAc, and a 2-fold dilution series (wells 1-16) was prepared for examination of activity. Those dilutions were layered onto EMM 
.'4)
.'5)
. Prototrophic cells (SpHT219) were suspended in water at OD 600 = 0.01 and spotted onto general EMM media containing isolated (R)-1 at a starting concentration of 1.0×10 5 ng/mL. The plate was incubated for 3 days.
4.=$>00$?@A8@<BC). Supplementary Note Scheme 1. Synthesis of racemic 10-hydroxyoctadec-8-enoic acid derivatives
10-hydroxyoctadec-8-ynoic acid (rac-4)
A solution of S1 (163.5 mg, 1.06 mmol) in dry THF (11 mL) under Ar atmosphere was cooled to −78 °C. n-BuLi (1.5 mL of a 1.55 M hexane solution, 2.33 mmol) was added dropwise via syringe. The resulting mixture was stirred at −78 °C for 1 h, and then warmed to room temperature, and stirred for another 1 h. The mixture was cooled to −78 °C again, and nonanal (0.2 mL, 1.17 mmol) was added slowly via syringe. The mixture was stirred at −78 °C for 1 h before being allowed to warm to room temperature, and then stirred for 15 h. The reaction was quenched by addition of a saturated aqueous solution of NaHCO 3 . The resulting mixture was extracted thrice with Et 2 O. The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (Hexane/EtOAc 5:1) to give rac-4 (164.7 mg, 52%) as a colorless oil. Hz, 3H). 13 C NMR (CDCl 3 , 100 MHz): δ 178. 7, 85.4, 81.6, 62.9, 38.3, 33.9, 32.0, 29.7, 29.44, 29.39, 28.6, 28.4 (2C), 25.4, 24.6, 22.8, 18.7, 14.3 
10-hydroxyoctadec-8-enoic acid (a mixture of rac-3 and rac-2)
To a solution of rac-4 (10 mg, 0.034 mmol) in EtOH (0.5 mL), Et 2 O (1.0 mL) and NH 3 (approx. 1.0 mL) was added Na metal (a few pieces) until the color remained dark blue. After 1.5 h, the mixture was warmed to room temperature, and NH 3 was allowed to evaporate. The residue was neutralized with a 2 M aqueous solution of HCl until pH was 1-2, and then extracted thrice with Et 2 O. The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (Hexane/EtOAc 5:1).
1 H NMR revealed the existence of rac-4
(about 10%) in the product; therefore, the same reaction was conducted again to provide a mixture of rac-3 and rac-2 (5:1, 6.7 mg, 67%).
methyl (8E)-10-hydroxyoctadec-8-enoate ((E)-S2)
The obtained mixture of rac-3 and rac-2 (5:1, 6.7 mg, 0.022 mmol) was dissolved in a mixture of CH 2 Cl 2 and MeOH (5:1, 180 µL) and treated with (trimethylsilyl)diazomethane (0.6 M in hexane, 123 µL, 0.074 mmol) under Ar atmosphere at room temperature. The mixture was allowed to react for 1 h at room temperature. After the solvent was evaporated, the residue was dissolved in H 2 O and extracted twice with EtOAc. The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (Hexane/EtOAc 10:1) to give a mixture of (E)-S2 and (Z)-S2 (5:1, 5.8 mg, 83%) as a colorless oil. Pure (E)-S2 was obtained by HPLC separation (PEGASIL silica SP100 (250 mm × 100 mm), Hexane/EtOAc 6:1, 3 ml/min, 190 nm UV, retention time: E-isomer, 17.7 min). 1 H NMR (CDCl 3 , 400 MHz): δ 5.61 (dtd, J = 15.2 Hz, 6.4 Hz, 0.9 Hz, 1H), 5.44 (ddt, J = 15.2 Hz, 6.9 Hz, 1.4 Hz, 1H), 4.03 (br ddd, J = 6.9 Hz, 6.9 Hz, 3.7 Hz, 1H), 3.67 (s, 3H), 2.30 (t, J = 7.4 Hz, 2H), 2.02 (dt, J = 6.9 Hz, 6.4 Hz, 2H), 1.65-1.25 (m, 22H), 0.88 (t, J = 6.9 Hz, 3H). 13 C NMR (CDCl 3 , 100 MHz): δ 174. 5, 133.3, 132.1, 73.4, 51.6, 37.5, 34.2, 32.2, 32.0, 29.7 (2C), 29.4, 29.1 (2C), 28.8, 25.6, 25.0, 22.8, 14.3 (8E)-10-hydroxyoctadec-8-enoic acid (rac-3) To a solution of (E)-S2 (3 mg, 0.0096 mmol) in a mixture of THF and H 2 O (2:1, 600 µL), LiOH·H 2 O (2.4 mg, 0.058 mmol) was added as a powder. The resulting mixture was stirred at room temperature for 18 h. After that, H 2 O (10 mL) was added at 0 °C, and the solution was acidified by addition of a 2 M aqueous solution of HCl until pH was 2-3. The resulting mixture was extracted thrice with EtOAc. The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (Hexane/EtOAc 5:1) to give pure rac-3 (2.3 mg, 80%) as a white solid. 9, 133.3, 132.2, 73.4, 37.4, 34.0, 32.2, 32.0, 29.9, 29.7, 29.4, 29.0, 28.9, 28.7, 25.6, 24.7, 22.8, 14.3 (8Z)-10-hydroxyoctadec-8-enoic acid (rac-2) Compound rac-4 (8.0 mg, 0.027 mmol) and Lindlar catalyst (Aldrich, no. 20573-7, 1 mg) were mixed in THF (1 mL). The resulting suspension was stirred under H 2 atmosphere at room temperature for 2.5 h. The catalyst was removed by filtration through a short Celite ® pad, and the filtrate was concentrated in vacuo to give crude rac-2 (6.4 mg, 80%) as a colorless oil contaminated with rac-3 (approx. 2%). The crude material was converted to their methyl ester derivatives, which were then separated by HPLC to give pure compound (Z)-S2. The methyl group of (Z)-S2 was removed in a similar manner as in the synthesis of rac-3 to generate pure rac-2. (8Z)-10-acetoxyoctadec-8-enoic acid (rac-1) To a solution of rac-2 (1.0 mg, 3.35 µmol) in a mixture of Ac 2 O and pyridine (1:1, 100 µL) was added 4-dimethylaminopyridine (DMAP, 0.2 mg, 0.00188 mmol) at 0 °C. The resulting mixture was stirred at room temperature for 1 h. H 2 O (10 mL) was added at 0 °C, and the solution was acidified by addition of 2 M aqueous solution of HCl until the pH was 2-3. The resulting mixture was extracted thrice with EtOAc. The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (Hexane/EtOAc 5:1) to give rac-1 (1.2 mg, quant.) as a colorless oil. 
10-hydroxyoctadecanoic acid (rac-5)
Compound rac-4 (8.6 mg, 0.029 mmol) and 10 wt% Pd on carbon (Wako, no. 163-15272, 0.9 mg) were mixed in THF (1 mL). The resulting suspension was stirred under H 2 atmosphere at room temperature for 2.5 h. The solid was removed by filtration through a short Celite ® pad, and the filtrate was concentrated in vacuo. Scheme 2. Synthesis of optical pure (8Z)-10-hydroxyoctadec-8-enoic acid derivatives methyl 10-hydroxyoctadec-8-ynoate (rac-S3) Compound rac-4 (43 mg, 0.145 mmol) was dissolved in a mixture of CH 2 Cl 2 and MeOH (6:1, 700 µL) and treated with (trimethylsilyl)diazomethane (0.6 M in hexane, 800 µL, 0.479 mmol) under Ar atmosphere at room temperature. The mixture was allowed to react for 1 h at room temperature. After the solvent was evaporated, the residue was dissolved in H 2 O and extracted twice with EtOAc. The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (hexane/EtOAc 10:1) to give rac-S3 (34.4 mg, 76%) as a colorless oil. 1 H NMR (CDCl 3 , 400 MHz): δ 4.34 (m, 1H), 3.67 (s, 3H), 2.31 (t, J = 7.4 Hz, 2H), 2.20 (td, J = 6.9 Hz, 1.8 Hz, 2H), 1.76 (d, J = 5.5 Hz, 1H), 1.73-1.21 (m, 22H), 0.88 (t, J = 6.9 Hz, 3H). 13 C NMR (CDCl 3 , 100 MHz): δ 174. 4, 85.3, 81.7, 62.8, 51.6, 38.3, 34.1, 32.0, 29.6, 29.42, 29.36, 28.7, 28.5, 25.3, 24.9, 22.8 (2C) 
methyl (10S)-10-hydroxyoctadec-8-ynoate ((S)-S3)
Anhydrous isopropanol was deoxygenated by three freeze-thaw cycles. Compound S4 (6.7 mg, 0.0217 mmol) was dissolved in the deoxygenated isopropanol (110 µL), to which was added the Noyori hydrogen transfer catalyst Ru[(S,S)-Tsdpen](p-cymene) (7.84 mM in isopropanol, 110 µL, 0.869 µmol, 4 mol%) at room temperature. The resulting solution was stirred at room temperature for 1.5 h, and then concentrated in vacuo. The residue was purified by silica-gel flash column chromatography (Hexane/EtOAc 20:1) to give (S)-S3 (6.2 mg, 92%) as a colorless oil. Compound (R)-2 was synthesized from (R,Z)-S2 in a manner similar to the synthesis of rac-3. Approx. 2% of E-isomer of (R)-2 was contaminated.
The 1 H and 13 C NMR spectra and HRMS data for the (R)-2 were identical to those of the rac-2.
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